Regenerative Medicine in St. Louis

What regenerative medicine actually refers to

The phrase covers a wide range of practice, and the range is the problem. Used carefully, regenerative medicine in an orthopedic setting means using a patient’s own biological material — concentrated platelets, bone marrow aspirate — together with correction of the metabolic conditions that suppress repair, to give a joint, tendon or disc a better chance of healing on its own.

Used loosely, the same phrase gets attached to almost anything delivered by injection. Two clinics can both advertise regenerative medicine and be doing entirely different things, with entirely different evidence behind them. Anyone comparing options in St. Louis is really comparing three things: what is in the injection, who decides whether you need one, and what gets measured before and after.

What we do here

• Orthobiologics [platelet and marrow concentrate injections] — prepared from your own blood or marrow, placed under image guidance.
• Metabolic optimization [correcting the biology that blocks repair] — insulin resistance, vitamin D, thyroid, inflammatory load.
• Peptide therapy [targeted signaling support] — where it is appropriate and only alongside the rest.

We do not offer cultured or expanded stem cell products, amniotic or umbilical “stem cell” injections, or exosome therapy. That is a deliberate boundary, and it is worth asking any clinic you are considering to state theirs plainly.

Why a joint stops healing

A tendon or joint that has not recovered after a reasonable course of therapy is usually not failing for want of one more injection. It is failing because the repair process itself is impaired. Poor glycemic control, low vitamin D, chronic inflammatory load, disrupted sleep and certain medications all measurably slow tissue repair.

This is why the evaluation starts with blood work rather than a syringe. If the terrain is against you, an orthobiologic injection is being asked to work in conditions that were already defeating your own biology. Correcting what is correctable first is not a delay tactic — it is what gives the injection a fair chance, and sometimes it resolves enough on its own that the injection is not needed.

Who is a reasonable candidate — and who is not

Being honest about this is more useful than a longer list of conditions.

Often reasonable

• Early to moderate joint degeneration where cartilage and joint space remain.
• Tendon problems that have persisted past three months of appropriate therapy.
• Patients told to “wait until it is bad enough” for replacement, who would rather use that interval.
• People for whom surgery carries real risk, or who want to exhaust preservation first.

Often not

• Bone-on-bone joints with deformity and mechanical collapse — that is a surgical problem, and we will say so.
• Active infection, or an untreated malignancy.
• Pain with no identified generator and no willingness to complete the diagnostic work.
• Anyone who needs a guarantee. There is no honest one available in this field.

Results vary, some patients get little or no benefit, and a clinic that does not tell you that before taking payment is telling you something about itself.

Measured before treated, measured after

The evaluation is a sequence, not a menu. Imaging and history establish the mechanical picture; diagnostic blocks confirm which structure is actually generating the pain; laboratory work establishes whether your biology can support repair. Only then is a treatment chosen, and the same measures are repeated afterwards so that improvement is demonstrated rather than assumed.

If a course of treatment is not producing measurable change, the honest response is to stop and reconsider the diagnosis — not to sell a further series. Repeating an injection because three is a conventional number is not a clinical rationale.

How to compare regenerative medicine clinics

Five questions separate practices more reliably than any brochure:

• Who performs the injection, and under what guidance? Image guidance is the difference between placing a preparation in a structure and placing it near one.
• What exactly is being injected? Ask for the preparation by name, and ask what is known about it for your specific problem.
• What is measured before and after? If nothing is, no one can tell whether it worked.
• Who tells you when you are not a candidate? A practice that has never turned a patient away is not assessing candidacy.
• Is the metabolic picture part of the plan? Injecting into unaddressed metabolic disease is treating the site and ignoring the cause.

Where we are, and who we see

Regen.MD is at 4477 Woodson Rd, Suite 103, in 63134 — next to Lambert Airport, with on-site parking and direct access from I-70 and I-170. We see patients from across the metro on both sides of the river, including the City of St. Louis, Clayton, Chesterfield, St. Charles, and in Illinois Edwardsville and Maryville. The practice is licensed in Missouri and Illinois.

Conditions we most often evaluate: joint dysfunction, chronic back pain, neuropathic pain and metabolic inflammation.